Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Leissner

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Biotechniques|November 3, 2004
DNA nucleic acid sequence-based amplification-based genotyping for polymorphism analysisCecile Berard, Marie-Angélique Cazalis, Philippe Leissner, et al.
Current Gene Therapy|August 23, 2002
Transductional targeting with recombinant adenovirus vectorsValerie Legrand, Philippe Leissner, Arend Winter, et al.
Biotechniques|October 9, 2004
Multiparametric duplex real-time nucleic acid sequence-based amplification assay for mRNA profilingThibault Verjat, Elisabeth Cerrato, Marcel Jacobs, et al.
American Journal of Clinical Pathology|August 22, 2007
Urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA assessment in breast cancer by means of NASBA: correlation with protein expressionPierre-Jean Lamy, Thibault Verjat, Anne-Claire Servanton, et al.
BMC Cancer|September 2, 2006
Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancerPhilippe Leissner, Thibault Verjat, Thomas Bachelot, et al.
Plos One|March 18, 2016
Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular CarcinomaEun Sun Jang, Sook-Hyang Jeong, Jin-Wook Kim, et al.
BMC Endocrine Disorders|August 22, 2023
Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot studyKristin Gravdal, Katrine H Kirste, Krzysztofa Grzelak, et al.
Clinical Chemistry and Laboratory Medicine|December 27, 2005
NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancerPierre-Jean Lamy, Thibault Verjat, Malick Paye, et al.
Clinical Immunology (Orlando, Fla.)|December 15, 2004
Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shockAlexandre Pachot, Guillaume Monneret, Nicolas Voirin, et al.
Cancer Cell|December 21, 2004
Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cellsSandrine Valsesia-Wittmann, Maud Magdeleine, Sébastien Dupasquier, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Biotechniques|November 3, 2004
DNA nucleic acid sequence-based amplification-based genotyping for polymorphism analysisCecile Berard, Marie-Angélique Cazalis, Philippe Leissner, et al.
Current Gene Therapy|August 23, 2002
Transductional targeting with recombinant adenovirus vectorsValerie Legrand, Philippe Leissner, Arend Winter, et al.
Biotechniques|October 9, 2004
Multiparametric duplex real-time nucleic acid sequence-based amplification assay for mRNA profilingThibault Verjat, Elisabeth Cerrato, Marcel Jacobs, et al.
American Journal of Clinical Pathology|August 22, 2007
Urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA assessment in breast cancer by means of NASBA: correlation with protein expressionPierre-Jean Lamy, Thibault Verjat, Anne-Claire Servanton, et al.
BMC Cancer|September 2, 2006
Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancerPhilippe Leissner, Thibault Verjat, Thomas Bachelot, et al.
Plos One|March 18, 2016
Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular CarcinomaEun Sun Jang, Sook-Hyang Jeong, Jin-Wook Kim, et al.
BMC Endocrine Disorders|August 22, 2023
Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot studyKristin Gravdal, Katrine H Kirste, Krzysztofa Grzelak, et al.
Clinical Chemistry and Laboratory Medicine|December 27, 2005
NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancerPierre-Jean Lamy, Thibault Verjat, Malick Paye, et al.
Clinical Immunology (Orlando, Fla.)|December 15, 2004
Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shockAlexandre Pachot, Guillaume Monneret, Nicolas Voirin, et al.
Cancer Cell|December 21, 2004
Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cellsSandrine Valsesia-Wittmann, Maud Magdeleine, Sébastien Dupasquier, et al.
Pageof 3